PENERAPAN APLIKASI ANDROID UNTUK MENINGKATKAN KEAMANAN DAN KEPATUHAN PENGGUNAAN OBAT PASIEN DIABETES DI KLINIK PRATAMA
DOI:
https://doi.org/10.47219/ath.v10i2.613Keywords:
Diabetes melitus tipe 2, Hipoglikemia, Kepatuhan pengobatan, Mobile health.Abstract
Ketidakpatuhan pengobatan dan kejadian hipoglikemia merupakan hambatan signifikan dalam mencapai hasil terapi optimal pada pasien diabetes melitus tipe 2 (DMT2). Pendekatan mobile health berpotensi memperkuat pengelolaan mandiri pasien, khususnya di layanan primer. Penelitian ini bertujuan mengevaluasi efektivitas aplikasi Android "Gulik" terhadap kepatuhan pengobatan, kendali glikemik, dan keamanan terapi pada pasien DMT2, serta mengidentifikasi faktor psikososial yang memengaruhi kepatuhan. Randomized controlled trial dilakukan di salah satu klinik pratama di Jakarta (Juli-September 2025), melibatkan 72 pasien PROLANIS yang dibagi secara acak ke dalam kelompok intervensi ("Gulik" + perawatan rutin) atau kelompok kontrol (perawatan rutin). Hasil penelitian menunjukkan kelompok intervensi mencapai tingkat kepatuhan tinggi yang jauh lebih besar dibandingkan kontrol (83% vs 42%; p=0,001), dengan peluang patuh dua kali lipat lebih tinggi (RR=2,00; 95% CI 1,32–3,02). Penurunan kadar HbA1c yang lebih besar teramati pada kelompok intervensi (?0,8% vs ?0,3%; p=0,001). Selain itu, intervensi secara signifikan menurunkan risiko hipoglikemia (RR=0,30; p=0,032), dengan penurunan insiden sebesar ?14% dibandingkan peningkatan +3% pada kelompok kontrol (p=0,017). Analisis regresi logistik menunjukkan bahwa aplikasi meningkatkan peluang kepatuhan hingga tujuh kali lipat (OR=7,00). Faktor positif seperti keyakinan terhadap penyakit, dukungan sosial, dan motivasi diri meningkatkan kepatuhan, sedangkan kekhawatiran obat dan distres psikologis menghambatnya. Skor System Usability Scale (SUS) sebesar 79 mengindikasikan kegunaan yang baik. Kesimpulannya, aplikasi mobile health "Gulik" secara efektif meningkatkan kepatuhan, kendali glikemik, dan keamanan pada pasien DMT2, serta menegaskan peran penting faktor psikologis.
References
. Artik H. Commentary on Drug Safety: Importance, Issues and Role in Healthcare. J Dev Drugs. 2023;
. Tan Q. Drug Importance in Healthcare and Applications. Advance in Pharmacoepidemiology and Drug Safety. 2022;
. Herrera Comoglio R. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content. Br J Clin Pharmacol. 2020 Apr 1;86(4):779–90.
. Jimmy B, Jose J. Patient medication adherence: Measures in daily practice. Vol. 26, Oman Medical Journal. 2011. p. 155–9.
. Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life. Vol. 61, Medicina (Lithuania). Multidisciplinary Digital Publishing Institute (MDPI); 2025.
. Sletvold H, Sagmo LAB, Torheim EA. Impact of pictograms on medication adherence: A systematic literature review. Vol. 103, Patient Education and Counseling. Elsevier Ireland Ltd; 2020. p. 1095–103.
. International Diabetes Federation (IDF). IDF Diabetes Atlas 10th edition [Internet]. 2021. Available from: www.diabetesatlas.org
. Direktorat Pencegahan dan Pengendalian Penyakit Tidak Menular Kementrian Kesehatan. Buku Pedoman Hari Diabetes Sedunia 2024. 2024.
. Latief MS. Drug Related Problems (DRPs) penggunaan obat antidiabetik pada pasien rawat inap diabetes mellitus tipe 2. Indonesian Journal of Health Science. 2024 Aug 26;4(5):572–9.
. Peng Y, Wang H, Fang Q, Xie L, Shu L, Sun W, et al. Effectiveness of Mobile Applications on Medication Adherence in Adults with Chronic Diseases: A Systematic Review and Meta-Analysis [Internet]. Vol. 26, Journal of Managed Care & Specialty Pharmacy JMCP. 2020. Available from: www.jmcp.org
. Puspitasari AW, Kristina SA, Satibi, Prabandari YS. SoBat Kanker smartphone application to improve oral chemotherapy adherence among cancer patients in Indonesia: Development, usability, and feasibility pilot study. J Appl Pharm Sci. 2024 Mar 1;14(3):183–90.
. Fukushima A, Iessa N, Balakrishnan MR, Pal SN. Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience. BMC Med Inform Decis Mak. 2022 Dec 1;22(1).
. Gow K, Rashidi A, Whithead L. Factors Influencing Medication Adherence Among Adults Living with Diabetes and Comorbidities: a Qualitative Systematic Review. Curr Diab Rep. 2024 Feb 19;24(2):19–25.
. Wexler DJ, Krause-Steinrauf H, Crandall JP, Florez HJ, Hox SH, Kuhn A, et al. Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2019 Nov 1;42(11):2098–107.
. Hakami AM, Almutairi B, Alanazi AS, Alzahrani MA. Effect of Mobile Apps on Medication Adherence of Type 2 Diabetes Mellitus: A Systematic Review of Recent Studies. Cureus. 2024 Jan 7;
. Feuerstein-Simon C, Bzdick S, Padmanabhuni A, Bains P, Roe C, Weinstock RS. Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study. J Diabetes Sci Technol. 2018 Nov 1;12(6):1192–9.
. María Gómez A, Cristina Henao D, León Vargas F, Mauricio Muñoz O, David Lucero O, García Jaramillo M, et al. Efficacy of the mHealth application in patients with type 2 diabetes transitioning from inpatient to outpatient care: A randomized controlled clinical trial. Diabetes Res Clin Pract. 2022 Jul;189:109948.
. Pirdehghan A, Poortalebi N. Predictors of Adherence to Type2 Diabetes Medication. J Res Health Sci. 2016;16(2):72–5.
. Sendekie AK, Netere AK, Kasahun AE, Belachew EA. Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia. PLoS One. 2022 Sep 21;17(9):e0274971.
. Huang J, Ding S, Xiong S, Liu Z. Medication Adherence and Associated Factors in Patients With Type 2 Diabetes: A Structural Equation Model. Front Public Health. 2021 Nov 4;9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mutawalli Sjahid latief, Febri Hidayat

This work is licensed under a Creative Commons Attribution 4.0 International License.









